DAIICHI SANKYO COMPANY LIMITEDDAIICHI SANKYO COMPANY LIMITEDDAIICHI SANKYO COMPANY LIMITED

DAIICHI SANKYO COMPANY LIMITED

No trades
See on Supercharts

4568 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
4568 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company